Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 241

1.

Effect of combined vitamin D administration plus dietary intervention on oxidative stress markers in patients with metabolic syndrome: A pilot randomized study.

Makariou SE, Elisaf M, Challa A, Tellis C, Tselepis AD, Liberopoulos EN.

Clin Nutr ESPEN. 2019 Feb;29:198-202. doi: 10.1016/j.clnesp.2018.10.004. Epub 2018 Oct 24.

PMID:
30661687
2.

Pharmacology of PCSK9 Inhibitors: Current Status and Future Perspectives.

Tsouka AN, Tellis CC, Tselepis AD.

Curr Pharm Des. 2018;24(31):3622-3633. doi: 10.2174/1381612824666181010144823.

PMID:
30317986
3.

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

EAS Familial Hypercholesterolaemia Studies Collaboration; EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators.

Atherosclerosis. 2018 Oct;277:234-255. doi: 10.1016/j.atherosclerosis.2018.08.051.

PMID:
30270054
4.

Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?

Cinoku I, Mavragani CP, Tellis CC, Nezos A, Tselepis AD, Moutsopoulos HM.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):61-67. Epub 2018 Aug 13.

5.

Designing Natural Product Hybrids Bearing Triple Antiplatelet Profile and Evaluating Their Human Plasma Stability.

Tsiailanis A, Tsoumani M, Stylos EK, Chatziathanasiadou MV, Kellici TF, Mavromoustakos T, Tselepis AD, Tzakos AG.

Methods Mol Biol. 2018;1824:371-385. doi: 10.1007/978-1-4939-8630-9_22.

PMID:
30039419
6.

Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial.

Kalantzi KI, Ntalas IV, Chantzichristos VG, Tsoumani ME, Adamopoulos D, Asimakopoulos C, Bourdakis A, Darmanis P, Dimitriadou A, Gkiokas S, Ipeirotis K, Kitikidou K, Klonaris I, Kostaki A, Logothetis D, Mainas K, Mais T, Maragiannis A, Martiadou K, Mavronasos K, Michelongonas I, Mitropoulos D, Papadimitriou G, Papadopoulos A, Papaioakeim M, Sofillas K, Stabola S, Stefanakis E, Stergiou D, Thoma M, Zenetos A, Zisekas S, Goudevenos JA, Panagiotakos DB, Tselepis AD.

Curr Vasc Pharmacol. 2018 Jun 4. doi: 10.2174/1570161116666180605090520. [Epub ahead of print]

PMID:
29866011
7.

Circulating progenitor cells and their interaction with platelets in patients with an acute coronary syndrome.

Tatsidou PT, Chantzichristos VG, Tsoumani ME, Sidiropoulou S, Ntalas IV, Goudevenos JA, Stellos K, Tselepis AD.

Platelets. 2019;30(3):314-321. doi: 10.1080/09537104.2018.1430355. Epub 2018 Feb 16.

PMID:
29451832
8.

Effects of increased body weight and short-term weight loss on serum PCSK9 levels - a prospective pilot study.

Filippatos TD, Liberopoulos E, Georgoula M, Tellis CC, Tselepis AD, Elisaf M.

Arch Med Sci Atheroscler Dis. 2017 Oct 5;2:e46-e51. doi: 10.5114/amsad.2017.70502. eCollection 2017.

9.

Comparative Anti-Platelet Profiling Reveals a Potent Anti-Aggregatory Effect of CD34+ Progenitor Cell-Derived Late-Outgrowth Endothelial Cells in vitro.

Chantzichristos VG, Gkrozou F, Stellos K, Paschopoulos ME, Tselepis AD.

J Vasc Res. 2018;55(1):13-25. doi: 10.1159/000481779. Epub 2017 Dec 2.

PMID:
29197873
10.

Clopidogrel Therapy in Patients with Cardiovascular Disease Undergoing Transurethral Resection of the Prostate: A Step Towards Individualization.

Tzimas P, Tsoumani M, Giannakis D, Kalantzi K, Petrou A, Chantzichristos V, Sofikitis N, Papadopoulos G, Milionis H, Tselepis A.

Drugs Aging. 2017 Dec;34(12):917-923. doi: 10.1007/s40266-017-0504-4.

PMID:
29177885
11.

Tailoring naringenin conjugates with amplified and triple antiplatelet activity profile: Rational design, synthesis, human plasma stability and in vitro evaluation.

Stylos E, Chatziathanasiadou MV, Tsiailanis A, Kellici TF, Tsoumani M, Kostagianni AD, Deligianni M, Tselepis AD, Tzakos AG.

Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2609-2618. doi: 10.1016/j.bbagen.2017.08.018. Epub 2017 Aug 24.

PMID:
28844979
12.

Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity.

Zvintzou E, Lhomme M, Chasapi S, Filou S, Theodoropoulos V, Xapapadaki E, Kontush A, Spyroulias G, Tellis CC, Tselepis AD, Constantinou C, Kypreos KE.

J Lipid Res. 2017 Sep;58(9):1869-1883. doi: 10.1194/jlr.M077925. Epub 2017 Jul 12.

13.

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.

Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J, Elisaf MS, Germanidis G, Giouleme O, Karagiannis A, Karvounis C, Katsiki N, Kotsis V, Kountouras J, Liberopoulos E, Pitsavos C, Polyzos S, Rallidis LS, Richter D, Tsapas AG, Tselepis AD, Tsioufis K, Tziomalos K, Tzotzas T, Vasiliadis TG, Vlachopoulos C, Mikhailidis DP, Mantzoros C.

Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4. Review.

PMID:
28521870
14.

High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis.

Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, Tselepis AD, Giannopoulos S.

J Neurol Sci. 2017 May 15;376:112-116. doi: 10.1016/j.jns.2017.03.010. Epub 2017 Mar 9. Review.

PMID:
28431593
15.

Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand.

Moschonas IC, Kellici TF, Mavromoustakos T, Stathopoulos P, Tsikaris V, Magafa V, Tzakos AG, Tselepis AD.

Platelets. 2017 Dec;28(8):812-821. doi: 10.1080/09537104.2017.1282607. Epub 2017 Mar 7.

PMID:
28267389
16.

ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design.

Češka R, Paragh G, Reiner Ž, Banach M, Tokgözoğlu L, Susekov AV, Rašlová K, Freiberger T, Vohnout B, Rynkiewicz A, Goudev A, Dan GA, Gaiţă D, Pojskić B, Pećin I, Kayıkçıoğlu M, Mitchenko O, Ezhov MV, Latkovskis G, Petrulionienė Ž, Fras Z, Tasić N, Mirrakhimov EM, Murataliev T, Shek AB, Tuka V, Tselepis AD, Moubarak EM, Rasadi KA.

Vnitr Lek. Winter 2017;63(1):43-48.

PMID:
28225290
17.

ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology.

Češka R, Freiberger T, Susekov AV, Paragh G, Reiner Ž, Tokgözoğlu L, Rašlová K, Banach M, Vohnout B, Rynkiewicz A, Goudev A, Dan GA, Gaiţă D, Pojskić B, Pećin I, Kayıkçıoğlu M, Mitchenko O, Ezhov MV, Latkovskis G, Petrulionienė Ž, Fras Z, Tasić N, Mirrakhimov EM, Murataliev T, Shek AB, Tuka V, Tselepis AD, Moubarak EM, Al Rasadi K.

Vnitr Lek. Winter 2017;63(1):25-30.

PMID:
28225288
18.

Antiplatelet Agents and Anticoagulants: From Pharmacology to Clinical Practice.

Tsoumani ME, Tselepis AD.

Curr Pharm Des. 2017;23(9):1279-1293. doi: 10.2174/1381612823666170124141806. Review.

PMID:
28120727
19.

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.

EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz AJ, Akram A, Kondapally Seshasai SR, Cole D, Watts GF, Hovingh GK, Kastelein JJ, Mata P, Raal FJ, Santos RD, Soran H, Freiberger T, Abifadel M, Aguilar-Salinas CA, Alnouri F, Alonso R, Al-Rasadi K, Banach M, Bogsrud MP, Bourbon M, Bruckert E, Car J, Ceska R, Corral P, Descamps O, Dieplinger H, Do CT, Durst R, Ezhov MV, Fras Z, Gaita D, Gaspar IM, Genest J, Harada-Shiba M, Jiang L, Kayikcioglu M, Lam CS, Latkovskis G, Laufs U, Liberopoulos E, Lin J, Lin N, Maher V, Majano N, Marais AD, März W, Mirrakhimov E, Miserez AR, Mitchenko O, Nawawi H, Nilsson L, Nordestgaard BG, Paragh G, Petrulioniene Z, Pojskic B, Reiner Ž, Sahebkar A, Santos LE, Schunkert H, Shehab A, Slimane MN, Stoll M, Su TC, Susekov A, Tilney M, Tomlinson B, Tselepis AD, Vohnout B, Widén E, Yamashita S, Catapano AL, Ray KK.

Atheroscler Suppl. 2016 Dec;22:1-32. doi: 10.1016/j.atherosclerosissup.2016.10.001. Epub 2016 Dec 7.

20.

Hypertrophic Mesenteric Adipose Tissue May Play a Role in Atherogenesis in Inflammatory Bowel Diseases.

Theocharidou E, Balaska A, Vogiatzis K, Tellis CC, Gossios TD, Athyros VG, Tselepis AD, Karagiannis A.

Inflamm Bowel Dis. 2016 Sep;22(9):2206-12. doi: 10.1097/MIB.0000000000000873.

PMID:
27508511

Supplemental Content

Loading ...
Support Center